P.O. Box 400301
Charlottesville, VA 22904
Michael M. Scheld, Haydn Wadley, and Judith White have been selected as its 2012 Distinguished Scientists. Read the UVA Today story.
John Holdren, Director of the White House's Office of Science and Technology Policy, visited UVa on Thursday, May 17, 2012. Read the UVA Today story.
An important message from Thomas C. Skalak, to Principal Investigators and Researchers occupying UVa laboratory space.
The 2nd Annual Presidential Research Poster Competition was held on May 4, 2012. Read the UVA Today story.
UVa's 4th Annual Venture Summit was held in April 2012. Read the UVA Today story.
Mark Crowell, UVa's Associate Vice President of Research and Executive Director of Innovation Partnerships & Commercialization, attends President Obama's signing of the America Invents Act. See the Daily Progress and UVA Today stories.
On September 26, 2011, the University of Virginia co-sponsored a U.S. Food & Drug Administration (FDA) workshop on medical device innovation, regulation, device education and translational research. (Information regarding the Bioresearch Monitoring program can be found here and here. Presentation regarding sponsor responsibilties can be found here. Presentation regarding investigator responsibilities can be found here.)
Mark Crowell, UVa's Executive VP for Innovation Partnerships and Commercialization, provides his insight and vision for the growth of biotechnology in Charlottesille. Read the Daily Progress story.
UVa and the Wallace H. Coulter Foundation have teamed together to create a $20 million endowment for translational research in biomedical innovation. This partnership will foster research collaboration between biomedical engineers and clinicians, resulting in new technologies to improve patient care and human health.
Three of the UVa's most accomplished faculty researchers – physicist Thomas F. Gallagher, pharmacologist Patrice G. Guyenet and microbiologist Kodi S. Ravichandran – have been selected to receive the University's 2011 Distinguished Scientist Awards.
UVa's Biomedical Innovation Fund has awarded $265,000 to six biomedical research projects that will advance health care and create economic growth.
UVa's 3rd Annual Venture Summit was held on March 3-4, 2011. Read about how entrepreneurs and investors are linking together at UVa to "Change the World". The Venture Summit also included a pitch session, featuring companies based on UVa research or with alumni connections.
Read about Tom Skalak's vision for UVa's research enterprise.